Pictet Asset Management (UK)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $4.93M | Sell |
160,050
-127,286
| -44% | -$3.92M | 0.01% | 846 |
|
|
2021
Q1 | $7.52M | Sell |
287,336
-67,450
| -19% | -$1.77M | 0.01% | 733 |
|
|
2020
Q4 | $8.93M | Sell |
354,786
-23,100
| -6% | -$581K | 0.01% | 648 |
|
|
2020
Q3 | $7.88M | Sell |
377,886
-34,197
| -8% | -$713K | 0.01% | 613 |
|
|
2020
Q2 | $9.79M | Sell |
412,083
-39,300
| -9% | -$933K | 0.02% | 529 |
|
|
2020
Q1 | $8.12M | Buy |
451,383
+56,500
| +14% | +$1.02M | 0.02% | 513 |
|
|
2019
Q4 | $9.37M | Sell |
394,883
-49,049
| -11% | -$1.16M | 0.02% | 586 |
|
|
2019
Q3 | $12.2M | Buy |
443,932
+40,400
| +10% | +$1.11M | 0.03% | 476 |
|
|
2019
Q2 | $13.4M | Sell |
403,532
-68,581
| -15% | -$2.27M | 0.03% | 460 |
|
|
2019
Q1 | $16.5M | Buy |
472,113
+75,089
| +19% | +$2.63M | 0.04% | 425 |
|
|
2018
Q4 | $13.2K | Buy |
397,024
+36,680
| +10% | +$1.22K | 0.03% | 444 |
|
|
2018
Q3 | $18.1M | Sell |
360,344
-21,922
| -6% | -$1.1M | 0.04% | 428 |
|
|
2018
Q2 | $22.9M | Sell |
382,266
-130,549
| -25% | -$7.81M | 0.05% | 369 |
|
|
2018
Q1 | $23.5M | Sell |
512,815
-112,629
| -18% | -$5.16M | 0.06% | 352 |
|
|
2017
Q4 | $24.9M | Buy |
625,444
+134,161
| +27% | +$5.35M | 0.06% | 340 |
|
|
2017
Q3 | $19.7M | Buy |
491,283
+400,083
| +439% | +$16M | 0.06% | 368 |
|
|
2017
Q2 | $3.43M | Buy |
91,200
+6,100
| +7% | +$229K | 0.01% | 693 |
|
|
2017
Q1 | $2.66M | Sell |
85,100
-2,800
| -3% | -$87.7K | 0.01% | 731 |
|
|
2016
Q4 | $2.22M | Buy |
+87,900
| New | +$2.22M | 0.01% | 735 |
|
|
2015
Q1 | – | Sell |
-238,300
| Closed | -$1.98M | – | 888 |
|
|
2014
Q4 | $1.98M | Buy |
238,300
+10,900
| +5% | +$90.5K | 0.01% | 753 |
|
|
2014
Q3 | $1.98M | Buy |
+227,400
| New | +$1.98M | 0.01% | 737 |
|